Downloads

  1. Retention And Access In NSCLC Clinical Trials 5/12/2026

    Helping participants navigate respiratory limitations, fatigue, and complex visit schedules in Non-Small Cell Lung Cancer (NSCLC) studies.

  2. How To Best Navigate The Global Clinical Trial Registry Ecosystem 5/12/2026

    This presentation is your GPS, guiding you on a path that includes harmonization initiatives intended to improve transparency and data consistency across registries.

  3. Applying AI to Study Simulation: From Design to Analysis 5/12/2026

    See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

  4. State of Materiovigilance: Gaps, Technology & Outsourcing 5/12/2026

    Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.

  5. Inside The Evolution Of Clinical Trials: Insights From Deepak Ananthan 5/12/2026

    From unlocking structured clinical data to AI, interoperability, and patient‑centric trial design, Deepak shared where the industry is heading — and the opportunities organisations should act on now.

  6. DHTs: Accelerate Huntington's Disease Research And Drug Development 5/12/2026

    Discover how digital health technologies are reshaping Huntington’s Disease trials with real-world data insights. Watch now to explore the future of HD measurement.

  7. The U.S. Clinical Trial Recruiting Pipeline Report – May 2026 5/12/2026

    This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from March 7 to May 1, 2026. 

  8. Accelerate Participant Enrollment With Better Site Matches 5/11/2026

    With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.

  9. Breaking Silos In Drug Development: The Power Of An Integrated Model 5/11/2026

    Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.

  10. Safe And Scalable AI Deployment For Clinical Trials 5/11/2026

    When life sciences organizations lack a structured, evidence-based methodology for scaling AI tools safely and effectively, they put clinical development at risk. Partha Anbil and Partha Khot team up to share a practical approach to its implementation.